Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00887302 · ClinicalTrials.gov registry record

Metabolomics of Roux-en-Y Gastric Bypass (RYGB) With Gastrostomy

A clinical trial, sponsored by East Carolina University.

Completed
Registry status
13
Enrollment target

NCT00887302: Completed study, sponsored by East Carolina University.

NCT00887302 is a clinical trial that has completed, run by East Carolina University. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00887302 has completed, sponsored by East Carolina University.

COMPLETED
Registry status
13 participants
Enrollment target

Study Summary

This study is an investigation of the "metabolomics of RYGB with gastrostomy."

Primary Outcome

The patient will be weighed after voiding. The weight will then be used to determine the amount of insulin to be administered during the minimal model. The following formulas will be used to calculate the insulin dosages: REGULAR INSULIN: body mass (kg) X 0.025 U

Interventions

  • PROCEDURE Gastric Band
  • PROCEDURE Gastric Sleeve
  • PROCEDURE Gastrostomy Tube

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2009-03-25
Est. Completion 2012-10-12
East Carolina University

58 total trials

What the finished NCT00887302 record still lists

NCT00887302 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.

The record links to 0 conditions, and to 3 interventions - of which Gastric Band is the first listed.

NCT00887302 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00887302 about?

NCT00887302 is a clinical study titled "Metabolomics of Roux-en-Y Gastric Bypass (RYGB) With Gastrostomy". This study is an investigation of the "metabolomics of RYGB with gastrostomy."

What is the current status of trial NCT00887302?

This trial is currently completed. The enrollment target is 13 participants. The study started on 2009-03-25. Estimated completion is 2012-10-12.

What interventions are being tested in trial NCT00887302?

The interventions under investigation include: Gastric Band (PROCEDURE), Gastric Sleeve (PROCEDURE), Gastrostomy Tube (PROCEDURE).

Who is sponsoring clinical trial NCT00887302?

This trial is sponsored by East Carolina University, which has 58 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00887302, the US trial registry maintained by the National Library of Medicine. NCT00887302 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.